Skip to content

Prosthetic Device in Children With Upper Congenital Limb Deficiency

Evaluation of 3D Printed Myoelectric Prosthetics in Children With Upper Congenital Limb Deficiency

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04059107
Enrollment
20
Registered
2019-08-16
Start date
2019-07-03
Completion date
2021-12-31
Last updated
2021-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Limb Deformities, Congenital

Brief summary

This is a study being performed to evaluate the safety and effectiveness of 3D printed myoelectric prosthetic devices in children with a congenital upper limb deficiency.

Detailed description

The purpose of this study is to learn more about whether myoelectric prosthetic devices would be beneficial and useful for children. The study protocol specifies 4 study visits over the course of a year at the following intervals: baseline, 3 month, 6 month, 12 months. In following the protocol, each study visit will use the Assessment of Capacity for Myoelectric Control (ACMC) functional testing. The study participants will also complete several parent-child reported health related quality of life and musculoskeletal questionnaires. Specifically, the Pediatric Outcomes Data Collection Instrument (PODCI), the Pediatric Quality of Life Inventory (PedsQL), and the Children's Hand-Use Experience Questionnaire (CHEQ) will be used to measure efficacy of the myoelectric devices..

Interventions

DEVICE3D Printed Myoelectric Prosthetic Device

3D Printed Myoelectric Prosthetic Device

Sponsors

Limbitless Solutions
CollaboratorUNKNOWN
University of Central Florida
CollaboratorOTHER
Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Children between the ages of 6 to 17 with congenital/infant upper limb deficiency identified by Limbitless Solutions will be referred to OHSU for evaluation and selection. * All approved and consented subjects will receive a Limbitless 3D printed myoelectric device as delivered by established protocol. * Preference will be given to children with long term previous experience with Limbitless Solutions' bionic systems.

Exclusion criteria

* Non English-speaking children and families. Due to the entirely volunteer nature of this project, the investigators are unable to hire appropriate translation services or create translated forms and surveys in other languages currently. * Shoulder or wrist disarticulation will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Primary Safety Endpoint - Measuring safety of the device through adverse event reporting.12 monthsThe safety of the device will be measured through parental reporting and recorded observations of adverse events.
Children's experiences of using the myoelectric device while performing bi-manual tasks as assessed using a self-report questionnaire.12 monthsThis assessment will measure the ability of the user to perform day-to-day tasks on three scales: grasp, performance time, and level of frustration.
Detects expected change in a person's ability to to do various functions while performing a specific task and scoring their motions.12 monthsThis assessment will evaluate the ability of the myoelectric device use on functions that involve griping, holding, releasing, and coordinating between limbs using the Assessment of Capacity for Myoelectric Control (ACMC).
This self-report or parent-report tool is used to assess musculoskeletal health of the myoelectric device user.12 monthsThis assessment contains six scales Upper Extremity Physical Function; Mobility/Transfers; Sports/Physical Function; Pain/Comfort; Happiness; and Global Function.
A self-report and parent-report sectional approach to measuring health-related quality of life.12 monthsThis assessment uses four generic core scales including: physical health, emotional functioning, social functioning, and school functioning.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026